FHL5 antibody (N-Term)
Quick Overview for FHL5 antibody (N-Term) (ABIN6757141)
Target
See all FHL5 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- Reacts with the N terminus of ACT (activator of CREM in testis).
-
Purification
- Immunoaffinity purified
-
Immunogen
-
N terminus of ACT (activator of CREM in testis).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
-
Approved: ELISA, WB (1:250 - 1:500)
Usage: Suitable for use in Western Blot and ELISA. Western Blot: 1:250-1:500. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.2, 0.01 % sodium azide, 40 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Short term: 4°C. Long term: Store at -20°C. Avoid freeze-thaw cycles.
-
-
- FHL5 (Four and A Half LIM Domains 5 (FHL5))
-
Alternative Name
- FHL5
-
Background
-
Name/Gene ID: FHL5
Synonyms: FHL5, Activator of CREM in testis, Four and a half LIM domains 5, KIAA0776, LIM protein ACT, DJ393D12.2, FHL-5, RP3-393D12.2 -
Gene ID
- 9457
Target
-